MarketInOut Stock Screener Log In | Sign Up

Lunit Inc

KRX • Healthcare • Health Information Services • Quote as of 10/30/2026
Lunit Inc stock price and volume chart

Company Profile

IndustryHealth Information Services
SectorHealthcare
ExchangeKRX
Market Capitalization1,071,453 mln
Float62.75 mln

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.27
Manipulation likely

1-Year Forecast

10,150
Downside risk

Relative Strength

99 / 100
Top performer

Debt / Equity

0.33
Low leverage

Pre-Tax Margin

-59%
Severely loss-making

Business Description

Founded in Seoul in 2013, Lunit develops artificial intelligence tools that help doctors detect and analyze cancer more accurately. Its software supports chest and breast imaging as well as tumor analysis at the cellular level. The company works alongside major global pharmaceutical and life sciences firms, including AstraZeneca, Daiichi Sankyo, and Agilent Technologies, to advance cancer research and drug development.

Key Fundamentals

EPS-1,467
ROE-30.93
RPS1,461
ROIC-13.06
ROA-13.21
EBITDA, mln-13,561
EV / EBITDA-52.72
EV / EBIT-29.44
Revenue, mln91,818
EV / Revenue7.79

Quote Details

Last 15,690
Change 710 (4.74%)
Open 14,980
Volume 3,974,602
Turnover 62,361,505,792
Average Volume 1,630,779

Financial Ratios

Pre-Tax Profit Margin-59
Current Ratio1.10
Price / Book2.44
Price / Tangible Book21.28
Debt / Equity0.33
Price / Sales7.70

Financial Strength

Altman Z-Score1.14
Piotroski F-Score 6 / 9
Beneish M-Score-1.27
1-Year Target Price10,150

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 38.85% 100 / 100   
1 Month 32.97% 99 / 100   
2 Months 69.62% 99 / 100   
6 Months -12.22% 69 / 100   
1 Year -23.56% 38 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog